Cargando…
Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells
The recombinant canarypox virus ALVAC is being extensively studied as vaccine vector for the development of new vaccine strategies against chronic infectious diseases and cancer. However, the mechanisms by which ALVAC initiates the immune response have not been completely elucidated. In order to det...
Autores principales: | Harenberg, Anke, Guillaume, Florine, Ryan, Elizabeth J., Burdin, Nicolas, Spada, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115550/ https://www.ncbi.nlm.nih.gov/pubmed/18691624 http://dx.doi.org/10.1016/j.vaccine.2008.07.050 |
Ejemplares similares
-
The Canarypox-virus vaccine vector ALVAC triggers the release of IFN-γ by Natural Killer (NK) cells enhancing Th1 polarization
por: Ryan, Elizabeth J., et al.
Publicado: (2007) -
A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells
por: Eller, Michael A., et al.
Publicado: (2011) -
Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013) -
Gene Expression Profiling of Human Monocyte-derived Dendritic Cells – Searching for Molecular Regulators of Tolerogenicity
por: Schinnerling, Katina, et al.
Publicado: (2015) -
Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human Primates
por: Herrera, Carolina, et al.
Publicado: (2022)